A Clinical study of two source plants of Shalparni in VataraktaÂ

A Pharmacotherapeutical study of two source plants of Shalaparni - Desmodium gangeticum DC. and Flemingia strobilifera (L.)W.T. Aiton in Vatarakta

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/06/008750

Enrollment

Registered

2017-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Early symptoms and symptoms of Vatarakta gout

Interventions

Intervention1: Shalaparni Desmodium gangeticum: orally kwatha 50ml bd before food with milk for 4 weeks follow up 2 weeks Control Intervention1: Shalaparni source Flemingia strobilifera: orally kwatha

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical signs and symptoms of purvarupa early symptoms and rupa symptoms of Vatarakta gout Patients having classical signs and symtoms without sandhivaikalya joint deformity

Exclusion criteria

Exclusion criteria: Patients below 18 and above 70 years of age Patients having sandhivaikalya joint deformity and of Gambhira Vatarakta deep seated gout Patients suffering from any systemic diseases like Diabetes Hypertension Cardiac Anomaly Chronic renal failure Liver cirrhosis Pregnant and lactating mother

Design outcomes

Primary

Measure	Time frame
Change in classical symptoms of Vatarakta Episodes of joint pain Burning sensation in joints Parasthesia of joints Discoloration on joints FatigueTimepoint: 4 weeks study and 2weeks follow up	—

Secondary

Measure	Time frame
Changes in Biochemical heamatological parametersTimepoint: 4 weeks study and 2weeks follow up	—

Countries

India

Contacts

Public ContactB R Patel

IPGT and RA Jamnagar GAU

brpayu@gmail.com9427574590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026